NASDAQ:AGTC

Applied Genetic Technologies SEC Filings & 10K Form

$3.89
+0.17 (+4.57 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.68
$3.91
50-Day Range
$3.62
$6.04
52-Week Range
$3.54
$9.67
Volume1.36 million shs
Average Volume2.65 million shs
Market Capitalization$166.31 million
P/E RatioN/A
Dividend YieldN/A
Beta2.33

SEC Filings

Applied Genetic Technologies (NASDAQ:AGTC) SEC Filings

DateFilerForm TypeView
04/26/2021
3:36 PM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2021
11:15 PM
Applied Genetic Technologies (Filer)
Form EFFECT
04/02/2021
4:12 PM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2021
3:40 PM
Applied Genetic Technologies (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/12/2021
1:56 PM
Applied Genetic Technologies (Subject)
Portolan Capital Management, LLC (Filed by)
Form SC 13G/A
02/12/2021
1:42 PM
Applied Genetic Technologies (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
Form SC 13G/A
02/12/2021
5:06 AM
Applied Genetic Technologies (Subject)
INTERWEST PARTNERS VIII LP (Filed by)
Form SC 13G/A
02/11/2021
3:16 PM
Applied Genetic Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/11/2021
6:20 AM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2021
2:12 PM
Applied Genetic Technologies (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G/A
02/10/2021
2:04 PM
Applied Genetic Technologies (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
02/09/2021
4:01 PM
Applied Genetic Technologies (Subject)
Stichting Aescap 2.0 (Filed by)
Form SC 13G/A
02/02/2021
9:29 AM
Applied Genetic Technologies (Subject)
Empery Asset Management, LP (Filed by)
Form SC 13G
02/01/2021
3:08 PM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2021
3:19 PM
Applied Genetic Technologies (Filer)
Form 424B5
01/27/2021
3:47 PM
Applied Genetic Technologies (Filer)
Form 424B5
01/27/2021
3:29 PM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2020
3:18 PM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2020
4:50 PM
Applied Genetic Technologies (Issuer)
VANLENT ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
4:46 PM
Applied Genetic Technologies (Issuer)
Rosen James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
4:39 PM
Applied Genetic Technologies (Issuer)
Magovcevic-Liebisch Ivana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
4:20 PM
Applied Genetic Technologies (Issuer)
HURWITZ EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
4:15 PM
Aliski William (Reporting)
Applied Genetic Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
4:10 PM
Applied Genetic Technologies (Issuer)
Koenig Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
3:14 PM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2020
3:23 PM
Applied Genetic Technologies (Filer)
Form DEFA14A
11/02/2020
3:21 PM
Applied Genetic Technologies (Filer)
Form DEF 14A
09/28/2020
12:51 PM
Applied Genetic Technologies (Subject)
Portolan Capital Management, LLC (Filed by)
Form SC 13G
09/18/2020
3:08 PM
Applied Genetic Technologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/18/2020
3:06 PM
Applied Genetic Technologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/17/2020
3:09 PM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2020
6:15 AM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2020
5:22 PM
Applied Genetic Technologies (Issuer)
Potter Stephen W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
5:15 PM
Applied Genetic Technologies (Issuer)
Shearman Mark S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
5:08 AM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2020
7:20 PM
Applied Genetic Technologies (Issuer)
Potter Stephen W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
7:11 PM
Applied Genetic Technologies (Issuer)
Sullivan William A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
7:08 PM
Applied Genetic Technologies (Issuer)
Washer Susan B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
7:07 PM
Applied Genetic Technologies (Issuer)
Shearman Mark S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2020
6:18 AM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
6:12 AM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2020
3:09 PM
Applied Genetic Technologies (Filer)
Form 8-K/A
04/07/2020
6:02 AM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
6:02 AM
Applied Genetic Technologies (Subject)
INTERWEST PARTNERS VIII LP (Filed by)
Form SC 13G/A
02/11/2020
3:56 PM
Applied Genetic Technologies (Subject)
BIOGEN INC. (Filed by)
Form SC 13G/A
02/06/2020
11:15 PM
Applied Genetic Technologies (Filer)
Form EFFECT
01/29/2020
4:29 PM
Applied Genetic Technologies (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/27/2020
4:20 PM
Applied Genetic Technologies (Subject)
Stichting Aescap 2.0 (Filed by)
Form SC 13G/A
01/16/2020
8:31 AM
Applied Genetic Technologies (Filer)
Form CT ORDER
01/10/2020
3:20 PM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2019
3:33 PM
Applied Genetic Technologies (Issuer)
Inspirational Visions B.V. (Reporting)
Krol Patrick Johan Hendrik (Reporting)
Privium Fund Management B.V. (Reporting)
Stichting Aescap 2.0 (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
3:44 PM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2019
5:14 PM
Applied Genetic Technologies (Issuer)
VANLENT ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
5:07 PM
Applied Genetic Technologies (Issuer)
Rosen James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
4:56 PM
Applied Genetic Technologies (Issuer)
Magovcevic Ivana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
4:50 PM
Applied Genetic Technologies (Issuer)
HURWITZ EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
4:45 PM
Aliski William (Reporting)
Applied Genetic Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
4:39 PM
Applied Genetic Technologies (Issuer)
Koenig Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
4:03 PM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2019
4:17 PM
Applied Genetic Technologies (Issuer)
Inspirational Visions B.V. (Reporting)
Krol Patrick Johan Hendrik (Reporting)
Privium Fund Management B.V. (Reporting)
Stichting Aescap 2.0 (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
4:14 PM
Applied Genetic Technologies (Issuer)
Inspirational Visions B.V. (Reporting)
Krol Patrick Johan Hendrik (Reporting)
Privium Fund Management B.V. (Reporting)
Stichting Aescap 2.0 (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/21/2019
3:10 PM
Applied Genetic Technologies (Subject)
Stichting Aescap 2.0 (Filed by)
Form SC 13G/A
11/12/2019
3:53 PM
Applied Genetic Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2019
4:16 PM
Applied Genetic Technologies (Filer)
Form DEF 14A
09/26/2019
3:24 PM
Applied Genetic Technologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/26/2019
3:21 PM
Applied Genetic Technologies (Filer)
Form 424B5
09/26/2019
3:16 PM
Applied Genetic Technologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/26/2019
3:11 PM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2019
3:22 PM
Applied Genetic Technologies (Issuer)
Washer Susan B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
7:07 PM
Applied Genetic Technologies (Issuer)
Krex Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:57 PM
Applied Genetic Technologies (Issuer)
Shearman Mark S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:51 PM
Applied Genetic Technologies (Issuer)
Potter Stephen W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:37 PM
Applied Genetic Technologies (Issuer)
Sullivan William A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
6:28 PM
Applied Genetic Technologies (Issuer)
Washer Susan B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:26 PM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2019
7:51 PM
Applied Genetic Technologies (Issuer)
Heah Theresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2019
7:38 PM
Applied Genetic Technologies (Issuer)
Heah Theresa (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/31/2019
7:28 PM
Applied Genetic Technologies (Issuer)
Feinsod Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
5:06 AM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2019
3:45 PM
Applied Genetic Technologies (Issuer)
Feinsod Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
6:11 AM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2019
3:39 PM
Applied Genetic Technologies (Issuer)
Feinsod Matthew (Reporting)
Form 4/A
06/13/2019
6:21 PM
Applied Genetic Technologies (Issuer)
Feinsod Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
3:04 PM
Applied Genetic Technologies (Issuer)
Koenig Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
3:02 PM
Applied Genetic Technologies (Issuer)
Feinsod Matthew (Reporting)
Form 4/A
05/15/2019
3:21 PM
Applied Genetic Technologies (Issuer)
Feinsod Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:10 PM
Applied Genetic Technologies (Issuer)
Krex Brian (Reporting)
Form 3/A
05/07/2019
3:33 PM
Applied Genetic Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
6:01 AM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2019
3:09 PM
Applied Genetic Technologies (Issuer)
Krex Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2019
3:08 PM
Applied Genetic Technologies (Issuer)
Krex Brian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/15/2019
4:42 PM
Applied Genetic Technologies (Issuer)
Feinsod Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
3:33 PM
Applied Genetic Technologies (Subject)
Stichting Aescap 2.0 (Filed by)
Form SC 13G
03/13/2019
4:16 PM
Applied Genetic Technologies (Issuer)
Feinsod Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
5:30 PM
Applied Genetic Technologies (Issuer)
Feinsod Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
6:34 AM
Applied Genetic Technologies (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
Form SC 13G
02/07/2019
3:06 PM
Applied Genetic Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/07/2019
6:09 AM
Applied Genetic Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2019
6:58 PM
Applied Genetic Technologies (Issuer)
Feinsod Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
7:29 PM
Applied Genetic Technologies (Issuer)
Rosen James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 5/8/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.